Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03133052

CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI) — CTA-MCI  

Amnestic Mild Cognitive Impairment Clinical Trial

Official title:
The CTA-MCI Study: a Randomized Controlled Clinical Trial to Evaluate the Effect of Cognitive Control Training on Episodic Memory Function in Patients With Amnestic Mild Cognitive Impairment

Clinical Trial Summary

This study evaluates the efficacy and mechanism of internet-based cognitive control training on episodic memory function in patients with amnestic Mild Cognitive Impairment(aMCI). Half of participants will receive adaptive internet-based cognitive control training program, while the other half will receive a fixed, primary difficulty level task.

Clinical Trial Description

Background:

Alzheimer's disease (AD) is a common dementia in elderly populations, and amnestic mild cognitive impairment (aMCI) refers to a transitional stage between normal aging and early dementia. Patients with aMCI are at higher risks of evolving toward AD. Although it has been widely recognized that early intervention of aMCI holds the potential to delay or even reverse the cognitive impairment, no treatment is available yet. Episodic memory dysfunction is the characteristic impairment in aMCI, cognitive control training significantly improved executive function in patients with aMCI . Whether and how cognitive control training improves episodic memory function in patients with aMCI remains largely unknown.

Objectives:

The primary objective of this double-blinded, randomized RCT is to assess whether internet-based cognitive control training in patients with amnestic Mild Cognitive Impairment improves their episodic memory function. The second objective is to evaluate the effect of cognitive control training on neural plasticity, including brain activation and white matter integrity, which are assessed by functional and structural MRI.

Patients and Methods:

The proposed study is a single-center, double-blinded, randomized controlled trial that will include 70 patients diagnosed with aMCI from the neurology clinics at The First Affiliated Hospital, Zhejiang University. The patients will be randomized to either a training or a control group. The intervention is internet-based cognitive control training performed for 30 minutes over 60 sessions. Neuropsychological assessment and functional magnetic resonance imaging (MRI) will be performed before and 12 weeks after training.

Relevance:

Currently there is no known treatment available for aMCI. The proposed study is to determine the efficacy of cognitive control training on episodic memory function in patients with aMCI. Secondly, using functional and structural MRI, this study is to reveal the potential mechanism underlying cognitive control training. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03133052
Study type Interventional
Source First Affiliated Hospital of Zhejiang University
Contact Junyang Wang
Phone +86-571-87235101
Email wjy999@foxmail.com
Status Recruiting
Phase N/A
Start date July 9, 2017
Completion date April 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT01525368 - Outcome Predictors of a Cognitive Intervention in aMCI N/A
Completed NCT00785759 - Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers Phase 2
Recruiting NCT05903573 - Training Response Artificial Intelligence Network (TRAIN) N/A
Completed NCT02562989 - [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) Phase 1
Completed NCT02910739 - An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) Phase 1
Not yet recruiting NCT04103463 - Interactive Stepping Exercise on Memory N/A
Completed NCT04185298 - mSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Amnestic Mild Cognitive Impairment N/A
Recruiting NCT04063956 - COG-REAGENT: COGnitive tRaining in patiEnts With Amnestic Mild coGnitive impairmENT N/A
Terminated NCT01953601 - Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Phase 3
Recruiting NCT06041152 - Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment Phase 2
Completed NCT01962038 - A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment N/A
Not yet recruiting NCT05987007 - Sleep Interventions and Neurocognitive Outcomes N/A
Recruiting NCT04240561 - Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia N/A
Completed NCT01767909 - The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Phase 2/Phase 3
Terminated NCT01072812 - Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment Phase 1
Completed NCT00643266 - Recollection Training in Healthy Older Adults and Older Adults With Amnestic Mild Cognitive Impairment N/A
Active, not recruiting NCT04504630 - Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury N/A
Terminated NCT00582855 - Effect of AQW051 in Patients With Memory Impairment Phase 2
Recruiting NCT05446584 - Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History Phase 2